Gregory Gale’s practice focuses on corporate and securities matters including private equity, mergers and acquisitions, securities and general corporate finance matters. Gregory represents publicly and privately held companies and leverage buyout firms.

He is recognized in The Best Lawyers in America and as an Ohio Super Lawyer. From 2005-2009 he was recognized as a Rising Star, one of the top 2.5 percent of Ohio lawyers age 40 or under, by Ohio Super Lawyers magazine.

Gregory is a member of the American, Georgia, Ohio State and Cleveland Metropolitan Bar Associations and is a former chair of the Corporate Section of the Cleveland Metropolitan Bar Association.

Representative Experience

Private Equity

• Representing a private equity fund in acquisitions of 11 printing companies in the United States and Mexico.
• Representing a private equity fund in acquisitions of six pressure-sensitive label companies in the United States, Canada and Chile.
• Representing a private equity fund in the acquisition of three packaging companies.
• Representing a private equity fund in the acquisition of two aerospace companies.
• Representing investors in the formation of a US$1 billion venture capital fund.
• Representing a private equity fund in the disposition of a private-label food business.
• Representing a private equity fund in the acquisition of two food businesses.
• Representing a private equity-owned portfolio company in its global coke and glass servicing operations.
• Representing shareholders in the sale of a global specialty chemical business to a private equity fund.
• Representing shareholders in the sale of a global telecommunications company to a private equity fund.
• Representing a private equity-owned portfolio company in a US$100 million debt offering.
• Representing a private equity-owned portfolio company in a US$200 million debt offering.
• Representing a private equity fund in a tender offer for and acquisition of a public home-incarceration device company.
• Representing a venture capital fund in the formation of a new fund valued at US$100 million.
• Representing a private equity fund in the acquisition of a non-US laboratory service company.
• Representing a private equity fund in the acquisition of a specialty chemical company.
• Representing a private equity-owned portfolio company in a US$170 million recapitalization/dividend.
• Representing a private equity-owned portfolio company in a US$120 million recapitalization/dividend.
• Representing a private equity-owned portfolio company in a US$50 million recapitalization/dividend.
• Representing a private equity-owned portfolio company in a US$40 million recapitalization/dividend.
• Representing a private equity-owned portfolio company in a US$130 million mezzanine financing transaction.
• Representing a private equity-owned pressure-sensitive label business in connection with a follow-on acquisition.
• Representing a private equity-owned bedding manufacturing business in connection with multiple debt financings.
• Representing a private equity fund in debt and equity investments in restaurant groups.
• Representing a private equity-owned oil and gas business in multiple follow-on acquisitions.

Securities

• Representing an issuer in a US$10.6 billion offering of stock.
• Representing an issuer in a US$7 billion offering of stock.
• Representing an Internet service provider in an initial public offering (IPO).
• Representing a food franchise company in an IPO.
• Representing a self-storage REIT in offerings of US$200 million in debt and US$100 million of stock.
• Representing an issuer in a shelf registration of US$400 million in stock.
• Representing a public technology company in the acquisition of two public companies and related US$90 million issuance of stock.
• Representing the investors in private placement of securities in a growth technology company.

International

• Representing an acquirer in the stock purchase of specialty chemicals companies in France, the Netherlands, Spain and the United Kingdom.
• Representing sellers in the sale of UK-, the Netherlands- and Brazil-based specialty chemicals businesses.
• Representing the acquirer in the purchase of an interest in a Chilean joint venture.
• Representing the acquirer in the purchase of a Mexico-based printing company.
• Representing the acquirer in the purchase of an interest in an Italian joint venture.
• Representing a public company in a joint venture in Ireland.
• Representing global operations of a US service-based company with subsidiaries in Australia, Brazil, China, Germany, India, Luxembourg, Mexico, Russia and the United Kingdom.
• Representing a Germany-based company in an IPO on foreign exchange.
• Representing a public company in a joint venture in Japan.
• Representing an acquirer of a medical services company in Ireland.
• Representing an acquirer of a global manufacturing business with subsidiaries in more than 30 countries.
• Representing an acquirer in the purchase of a global division from a UK-based target.
• Representing a UK-based company in the borrowing of US$1.5 billion in debt from non-UK banks.
• Representing a Hong Kong-based company in private placement of securities to a US-based investor group.
• Representing a Hong Kong private equity fund in multiple investments in US-based companies.
• Representing the acquirer in the purchase of assets of an insolvent Mexico-based company.